Business OpportunityUpdated on 29 October 2025
MediNexus
Innovation and Strategy Coordinator at Bellvitge University Hospital
Hospitalet de Llobregat, Spain
About
Complex clinical case management in healthcare is severely hampered by insufficient coordination among multidisciplinary specialists scattered across various institutions and regions. This often leads to suboptimal decision-making in patient care, coupled with an absence of clear traceability for crucial clinical actions, limited access to specialized expertise for all practitioners, and ultimately, significant inequalities in care delivery.
Medinexus is a digital solution supporting shared clinical decision-making. It enhances coordination by structuring, planning, and documenting multidisciplinary clinical sessions, thereby improving joint evaluation and decision-making. Accessible via secure, multilingual, interoperable interfaces (workstations, tablets, mobile) and integrated with existing clinical systems (HIS, PACS, EHRs, Teams), it enables complex case discussions in a single collaborative workspace. It facilitates agile exchange of structured and unstructured clinical data, supporting scheduled and urgent sessions in various formats.
The aim is to scale and adapt the solution into a transregional, interoperable platform for personalized clinical decision support. This includes integrating prioritization algorithms and exploring the incorporation of AI that align diagnostic and therapeutic recommendations with clinical practice guidelines and the latest evidence, acting as a support in the clinical sessions.
The project will focus on a highly relevant area—Rare Diseases—which typically require multidisciplinary management and is a top priority focus in Europe. Objectives:
1. Adapt the tool for deployment in other European regions, identifying required technical, linguistic, regulatory, and organizational adjustments.
2. Pilot multidisciplinary clinical sessions with MediNexus incorporating different european hospitals.
3. Evaluate the integration of AI-based decision support algorithms for an improvement of the clinical sessions
Stage
- TRL 6
Topic
- Other
- Rare diseases
Sector
- Health data
- Diagnostics
- Rare diseases
Type
- Co-development
- Regulatory expert
- Consortium partners
Organisation
Similar opportunities
Business Opportunity
vitalera: Making Hospital-at-Home a Reality with AI
- AI
- TRL 8
- Oncology
- Physiology
- Pediatrics
- Licensing
- Respiratory
- Health data
- Rare diseases
- Rare diseases
- Bioinformatics
- Cardiovascular
- Co-development
- Digestive system
- Consortium partners
- Regenerative medicine
- Research collaboration
- External causes of morbidity, mortality
- Injury, poisoning, other external causes
- Pregnancy, childbirth and the puerperium
- Musculoskeletal system, connective tissue
- Other symptoms, deviant clinical findings
- Diseases of the blood and immune disorders
- Diseases of the nervous system / neurology
- Mental and behavioural disorders / psychiatry /psychology
Nuria Pastor
General Manager at vitalera
Barcelona, Spain
Business Opportunity
- TRL 6
- TRL 7
- TRL 8
- Health data
- Rare diseases
- Research collaboration
- Congenital or chromosomal abnormalities
- Diseases of the blood and immune disorders
Jacques Riviere
Pediatric immunologist, researcher at Vall d'Hebron Research Institute (VHIR)
Barcelona, Spain
Business Opportunity
eSalut + – Remote Monitoring and Patient Empowerment Platform
- TRL 7
- TRL 8
- Other
- Health data
- Co-development
- Regulatory expert
- Clinical validation
- Consortium partners
MAR ELVIRA
Project Manager at Bellvitge University Hospital
Barcelona, Spain